secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001213900-24-003750
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial shareholders approve issuance of up to 3.0M shares upon warrant exercise
------------------------------------------------------------------------------

- Proposal 1 approved: 432,915 for, 51,550 against, 6,621 abstain; enables exercise of warrants from Oct 2023 private placement.
- Proposal 2 (adjournment) also approved but not needed; votes: 436,338 for, 47,809 against, 6,939 abstain.
- Warrant exercise could dilute existing common stock by over 20%, subject to Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390024003750/0001213900-24-003750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390024003750/ea191680-8k_adialpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-003750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer